Use App
Trending
News
Earnings
Newsletters
Work With Us
All
DIA
0.25%
SPY
0.40%
QQQ
0.55%
Trending
BTC
6.91%
HIMS
7.37%
NVDA
2.44%
AMZN
7.71%
SPY
0.40%
IREN
6.01%
QQQ
0.55%
AVGO
2.92%
STLA
21.70%
LBTYB
225.27%
BTC
6.91%
HIMS
7.37%
NVDA
2.44%
AMZN
7.71%
SPY
0.40%
IREN
6.01%
QQQ
0.55%
AVGO
2.92%
STLA
21.70%
LBTYB
225.27%
home
Symbol
CNSP
CNSP
Cns Pharmaceuticals Inc
7,858
Mkt Cap
$3.23M
Volume
32.00
52W High
$114.00
52W Low
$4.93
PE Ratio
-0.09
CNSP Fundamentals
Price
$4.55
Prev Close
$5.21
Open
$5.22
50D MA
$6.36
Beta
0.98
Avg. Volume
72,923.95
EPS (Annual)
-$466.44
P/B
0.30
Rev/Employee
$0.00
PE Ratio
-0.09
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.
Stocktwits
·
9mo ago
Full Article
<
...
1
>
Latest CNSP News
View
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile